July 14, 2016
Takeda Pharmaceutical said on July 13 that it has launched on a global initiative designed to raise awareness of inflammatory bowel disease (IBD) in Europe and the US. Takeda is currently marketing Entyvio (vedolizumab) in Europe and the US for...read more